SynthesisDisease markers2022

The Efficacy of Immune Checkpoint Inhibitors vs. Chemotherapy for KRAS-Mutant or EGFR-Mutant Non-Small-Cell Lung Cancers: A Meta-Analysis Based on Randomized Controlled Trials.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.